These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38527977)

  • 1. Improvement of Calcinosis in Dermatomyositis With Intravenous Immunoglobulin.
    Sakellariou GT; Katsigianni I
    J Clin Rheumatol; 2024 Jun; 30(4):e124. PubMed ID: 38527977
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy.
    Touimy M; Janani S; Rachidi W; Etaouil N; Mkinsi O
    Joint Bone Spine; 2013 Jan; 80(1):108-9. PubMed ID: 22999904
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
    Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
    Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of dermatomyositis with rhabdomyolysis, rescued by intravenous immunoglobulin.
    Mizoguchi F; Takada K; Ishikawa K; Mizusawa H; Kohsaka H; Miyasaka N
    Mod Rheumatol; 2015 Jul; 25(4):646-8. PubMed ID: 24252047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
    Shahani L
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin.
    Amano H; Nagai Y; Katada K; Hashimoto C; Ishikawa O
    Br J Dermatol; 2007 Jun; 156(6):1390-2. PubMed ID: 17459039
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment with intravenous high-dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia.
    Yoshimatsu Y; Kotani T; Fujiki Y; Oda K; Kataoka T; Yamairi K; Hata K; Otani K; Kamimori T; Fujiwara H
    Int J Rheum Dis; 2019 Feb; 22(2):321-324. PubMed ID: 26443969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin.
    Peñate Y; Guillermo N; Melwani P; Martel R; Hernández-Machín B; Borrego L
    J Am Acad Dermatol; 2009 Jun; 60(6):1076-7. PubMed ID: 19467386
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis.
    Galimberti F; Li Y; Fernandez AP
    J Am Acad Dermatol; 2015 Jul; 73(1):174-6. PubMed ID: 26089058
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term remission of severe refractory dermatopolymyositis with a weekly-scheme of immunoglobulin followed by rituximab therapy.
    Sánchez-Ramón S; Ravell JC; de la Torre I; Montoro M; Rodríguez-Mahou M; Carreño-Pérez L; Fernández-Cruz E; López-Longo FJ
    Rheumatol Int; 2010 Apr; 30(6):817-9. PubMed ID: 19536548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
    Lung; 2009; 187(3):201-6. PubMed ID: 19387736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile dermatomyositis.
    Halbert AR
    Australas J Dermatol; 1996 May; 37(2):106-8. PubMed ID: 8687325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Immunoglobulin and Dermatomyositis-Associated Venous Thromboembolism.
    Rotrosen ET; Zahedi Niaki O; Kassamali B; Lonowski S; Shahriari N; LaChance A; Vleugels RA
    JAMA Dermatol; 2023 Jun; 159(6):666-667. PubMed ID: 37163260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse Lacy Reticular Calcinosis in Juvenile Dermatomyositis.
    Taneja N; Gupta S; Patel U; Arava S; Gupta V
    J Clin Rheumatol; 2021 Sep; 27(6):e232-e233. PubMed ID: 32251056
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment With Rituximab in Juvenile Dermatomyositis: Effect on Calcinosis.
    Vargas Lebrón C; Ruiz Montesino MD; Moreira Navarrete V; Toyos Sainz de Miera FJ
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):368-370. PubMed ID: 30054253
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatomyositis panniculitis: a case report.
    Carroll M; Mellick N; Wagner G
    Australas J Dermatol; 2015 Aug; 56(3):224-6. PubMed ID: 24689899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of barium swallow radiographic abnormalities in a patient with dermatomyositis and severe dysphagia after high-dose intravenous immunoglobulins.
    Iannone F; Giannini M; Lapadula G
    J Clin Rheumatol; 2015 Jun; 21(4):227. PubMed ID: 26010190
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
    Martillotti J; Moote D; Zemel L
    Pediatr Radiol; 2014 Jan; 44(1):115-8. PubMed ID: 23839717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous ulcers of refractory adult dermatomyositis responsive to intravenous immunoglobulin.
    Peake MF; Perkins P; Elston DM; Older SA; Vinson RP
    Cutis; 1998 Aug; 62(2):89-93. PubMed ID: 9714905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.